Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.
暂无分享,去创建一个
James M. Harris | L. Zon | M. Dovey | W. Goessling | T. Schlaeger | D. Stroncek | J. Tisdale | R. Donahue | M. Metzger | T. North | M. Armant | P. Jin | N. Uchida | A. Bonifacino | Joseph J Stegner | Robyn S Allen | Xiao Guan | Robyn S. Allen
[1] Anthony E. Boitano,et al. Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells , 2010, Science.
[2] J. Dick,et al. Comparison of human cord blood engraftment between immunocompromised mouse strains. , 2010, Blood.
[3] H. Kiem,et al. Large animal models of hematopoietic stem cell gene therapy , 2010, Gene Therapy.
[4] L. Zon,et al. Resolving the controversy about N-cadherin and hematopoietic stem cells. , 2010, Cell stem cell.
[5] Ian A. White,et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. , 2010, Cell stem cell.
[6] Colleen Delaney,et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution , 2010, Nature Medicine.
[7] H. Broxmeyer,et al. New approaches for improving engraftment after cord blood transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] R. O’Keefe,et al. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. , 2009, Blood.
[9] H. Broxmeyer,et al. Experimental basis of cord blood transplantation , 2009, Bone Marrow Transplantation.
[10] J. Tisdale,et al. Development of a Human Immunodeficiency Virus Type 1-Based Lentiviral Vector That Allows Efficient Transduction of both Human and Rhesus Blood Cells , 2009, Journal of Virology.
[11] J. Sampath,et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. , 2009, Blood.
[12] L. Zon,et al. Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration , 2009, Cell.
[13] Marie-Laure Dichtel-Danjoy,et al. SoxF is part of a novel negative-feedback loop in the wingless pathway that controls proliferation in the Drosophila wing disc , 2009, Development.
[14] H. Lodish,et al. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.
[15] K. Ottersbach,et al. Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells , 2007, Proceedings of the National Academy of Sciences.
[16] K. Pollok,et al. Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. , 2007, Stem cells and development.
[17] M. Konopleva,et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] L. Zon,et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.
[19] D. Scadden,et al. Therapeutic targeting of a stem cell niche , 2007, Nature Biotechnology.
[20] S. Armstrong,et al. FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.
[21] B. Yeap,et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] D. Aronoff,et al. Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.
[23] R. Moon,et al. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation , 2006, Nature Medicine.
[24] C. Dunbar,et al. Large Animal Models for Stem and Progenitor Cell Analysis , 2005, Current protocols in immunology.
[25] J. Wingard,et al. Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors , 2002, Transfusion.
[26] N. Ferrara,et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.
[27] J. Campos-Ortega,et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.
[28] J. Jones,et al. Assessment of barriers to bone marrow donation by unrelated African-American potential donors. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[29] R. Willemze,et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. , 1995, Blood.
[30] J. Regan,et al. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. , 1994, Molecular pharmacology.
[31] B. Dörken,et al. Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. , 1993, Bone marrow transplantation.
[32] H. Broxmeyer,et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.